Exact Sciences CorporationEXASNASDAQ
LOADING
|||
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +12.78% | +10.29% | +10.86% | +15.99% | +20.05% |
| Gross Profit Growth | +6.88% | -9.65% | +12.15% | +15.18% | +18.81% |
| EBITDA Growth | -57.19% | -7983.98% | +0.00% | +52.28% | +87.05% |
| Operating Income Growth | -675.31% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | -4915.62% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | -4872.73% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | -4983.72% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +2.30% | +2.24% | +2.45% | +2.49% | +2.42% |
| Weighted Average Shares Diluted Growth | +0.39% | +2.24% | +2.45% | +2.49% | +2.42% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +469.43% | -32.33% | +0.00% | -16.86% | +58.54% |
| Free Cash Flow Growth | +0.00% | -68.96% | +0.00% | -34.44% | +68.82% |
| Receivables Growth | +32.81% | +22.27% | +16.30% | +33.91% | +15.57% |
| Inventory Growth | +3.12% | +27.38% | +37.38% | +34.64% | +20.29% |
| Asset Growth | +5.10% | -8.39% | -10.43% | -13.13% | -12.57% |
| Book Value per Share Growth | +0.55% | -25.30% | -25.31% | -24.53% | -23.93% |
| Debt Growth | +7.68% | +7.83% | -1.33% | -8.70% | -8.10% |
| R&D Expense Growth | -8.94% | -13.32% | -5.01% | -10.11% | +15.57% |
| SG&A Expenses Growth | +5.94% | +5.49% | +10.87% | +17.12% | +18.81% |